4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-040677
Chief Business Development Off sold 6,771 shares at an average $47.34 ($320,540)
- Chief Business Development Off acquired 6,771 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2020-07-01 | Option exercise | +2,604 | $6.55 | $17,056 | 2,604 | D |
| BENZENO SHARON Chief Business Development Off | 2020-07-01 | Option exercise | +2,604 | $6.55 | $17,056 | 5,208 | D |
| BENZENO SHARON Chief Business Development Off | 2020-07-01 | Option exercise | +1,563 | $7.27 | $11,363 | 6,771 | D |
| BENZENO SHARON Chief Business Development Off | 2020-07-01 | Sale | −5,571 | $47.17 | $262,784 | 1,200 | D |
| BENZENO SHARON Chief Business Development Off | 2020-07-01 | Sale | −1,200 | $48.13 | $57,756 | 0 | D |
| Derivatives | |||||||
| BENZENO SHARON Chief Business Development Off | 2020-07-01 | Option exercise · Stock Option (Right to Buy) | −2,604 | 41,667 | D | ||
| BENZENO SHARON Chief Business Development Off | 2020-07-01 | Option exercise · Stock Option (Right to Buy) | −2,604 | 70,313 | D | ||
| BENZENO SHARON Chief Business Development Off | 2020-07-01 | Option exercise · Common Stock (Right to Buy) | −1,563 | 46,875 | D | ||
| Open-market sales · 6,771 sh · avg $47.34 · $320,540 | |||||||
Loading xslF345X03/doc4.xml…